Skip to content

LIPOSCIENCE INC

Delisted

CIK 1168197fmd_126R4J3KH1VWXJRRH3FT3SESFMManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2011 to Sep 30, 2014, 12 periods

Latest annual · FY2013

Millions
Gross profit
42
Operating income
(11)
Net income
(13)
Free cash flow
(15)

Latest quarter · Q3 FY2014

Millions
Gross profit
6
Operating income
(4)
Net income
(4)
Free cash flow
(3)
Open Financials

LIPOSCIENCE INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2012ChangeSource
Gross profit$41.6 million$44.7 million-6.9%10-K 2014-03-28 · proof
Operating income-$10.7 million$1.9 million-648.8%10-K 2014-03-28 · proof
Net income-$12.5 million$1.3 million-1,102.8%10-K 2014-03-28 · proof
Cash from operating activities-$10.2 million$7.6 million-234.3%10-K 2014-03-28 · proof
Free cash flow-$14.8 million-$418,00010-K 2014-03-28 · proof
Total assets$72 million$47.7 million+51%10-K 2014-03-28 · proof
Total liabilities$24.2 million$29.9 million-19%10-K 2014-03-28 · proof
Cash and cash equivalents$49.6 million$24.8 million+100.2%10-K 2014-03-28 · proof
Total debt$0$15.7 million-100%10-Q 2014-08-13 · proof
What was LIPOSCIENCE INC's gross profit in fiscal 2013?
LIPOSCIENCE INC reported gross profit of $41.6 million for fiscal 2013 (the year ended Dec 31, 2013), against $44.7 million the year before (-6.9%). Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What was LIPOSCIENCE INC's operating income in fiscal 2013?
LIPOSCIENCE INC reported operating income of -$10.7 million for fiscal 2013 (the year ended Dec 31, 2013), against $1.9 million the year before (-648.8%). Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What was LIPOSCIENCE INC's net income in fiscal 2013?
LIPOSCIENCE INC reported net income of -$12.5 million for fiscal 2013 (the year ended Dec 31, 2013), against $1.3 million the year before (-1,102.8%). Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What was LIPOSCIENCE INC's cash from operating activities in fiscal 2013?
LIPOSCIENCE INC reported cash from operating activities of -$10.2 million for fiscal 2013 (the year ended Dec 31, 2013), against $7.6 million the year before (-234.3%). Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What was LIPOSCIENCE INC's free cash flow in fiscal 2013?
LIPOSCIENCE INC reported free cash flow of -$14.8 million for fiscal 2013 (the year ended Dec 31, 2013), against -$418,000 the year before. Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What are LIPOSCIENCE INC's total assets?
As of Dec 31, 2013, LIPOSCIENCE INC reported total assets of $72 million, against $47.7 million a year earlier (+51%). Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What are LIPOSCIENCE INC's total liabilities?
As of Dec 31, 2013, LIPOSCIENCE INC reported total liabilities of $24.2 million, against $29.9 million a year earlier (-19%). Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What are LIPOSCIENCE INC's cash and cash equivalents?
As of Dec 31, 2013, LIPOSCIENCE INC reported cash and cash equivalents of $49.6 million, against $24.8 million a year earlier (+100.2%). Source: the 10-K filed with the SEC on Mar 28, 2014. SEC
What is LIPOSCIENCE INC's total debt?
As of Dec 31, 2013, LIPOSCIENCE INC reported total debt of $0, against $15.7 million a year earlier (-100%). Source: the 10-Q filed with the SEC on Aug 13, 2014. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1168197&period_type=annual&limit=5"

Information only, not investment advice.